Test ID: PTAU
- pTau181 is a test to rule out Alzheimer’s Associated Amyloid Pathology
- Targeted for use during the assessment of patients with cognitive decline before the onset of Alzheimer’s disease symptoms.
- Aimed at patients aged 55 to 80 years old with subjective cognitive decline, non-specific cognitive impairment, or suspected mild cognitive impairment (MCI) and for patients undergoing evaluation for Alzheimer’s disease where amyloid pathology needs to be ruled out early.
- Targeted for use during the assessment of patients with cognitive decline before the onset of Alzheimer’s disease symptoms.
- Aimed at patients aged 55 to 80 years old with subjective cognitive decline, non-specific cognitive impairment, or suspected mild cognitive impairment (MCI) and for patients undergoing evaluation for Alzheimer’s disease where amyloid pathology needs to be ruled out early.
This diagnostic test is only available for referrals by medical doctors.
Turnaround time: 8 days
Sample Collection Instructions: Standard venepuncture procedure
Sample Requirements: Purple (EDTA)
Sample Stability: Postal NOT acceptable